相关实验视频

Updated: May 30, 2025

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

在清细胞细胞癌中,ADAM8的潜在预后和免疫学意义

Ming Chuan Chu¹, Zhi Lei Zhang¹, Zhi Qiang Wang²

¹Department of Urology, Weifang People's Hospital, Shandong Second Medical University, Weifang, China.

|January 31, 2025

概括

在癌中,A Disintegrin And Metalloproteinase 8 (ADAM8) 的水平升高,与更差的预后和免疫反应相关. 这表明ADAM8是癌治疗和免疫治疗的潜在目标.

科学领域:

在瘤学瘤学.
生物信息学是一种生物信息学.
癌症研究癌症研究

背景情况:

分解蛋白和金属蛋白酶8 (ADAM8) 与各种癌症有关.
它在清细胞细胞癌 (ccRCC) 中的作用需要进一步研究.

研究的目的:

调查ccRCC中ADAM8的预后和免疫学意义.
在ccRCC.中探索ADAM8作为潜在的治疗点.

主要方法:

使用TCGA,GEO和IHC对ccRCC中ADAM8表达和预后的分析.
功能丰富分析和CIBERSORT算法用于途径和瘤微环境分析.
使用TCIA和CMAP探索免疫疗法反应和药物发现.

主要成果:

在ccRCC组织中,ADAM8的表达显著升高.
更高的ADAM8水平与更差的预后相关,并作为一个独立的风险因素.
ADAM8的表达与免疫细胞透,免疫疗法反应和已识别的潜在ccRCC药物有关.

结论:

ADAM8显著影响ccRCC的发展,进展,免疫疗法和预后.
ADAM8代表了对ccRCC管理的有前途的预后和免疫治疗目标.

更多相关视频

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

A Next-generation Tissue Microarray ngTMA Protocol for Biomarker Studies

Published on: September 23, 2014

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Immunohistochemical Staining of B7-H1 PD-L1 on Paraffin-embedded Slides of Pancreatic Adenocarcinoma Tissue

Published on: January 3, 2013

相关概念视频

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...